Company Filing History:
Years Active: 2016-2017
Title: The Innovations of Robert Vernon Stanton
Introduction
Robert Vernon Stanton is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of pharmacology, particularly through his work on prostaglandin EP3 receptor antagonists. With a total of 2 patents, Stanton's innovations have the potential to impact therapeutic approaches in medicine.
Latest Patents
Stanton's latest patents focus on antagonists of the prostaglandin EP3 receptor. These patents detail processes for creating these antagonists and methods for administering them to mammals in need. The implications of this research could lead to advancements in treating various medical conditions.
Career Highlights
Stanton is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.
Collaborations
Some of Stanton's notable coworkers include Kevin Barry Bahnck and David James Edmonds. Their collaborative efforts enhance the innovative environment at Pfizer, fostering advancements in pharmaceutical research.
Conclusion
Robert Vernon Stanton's contributions to the field of pharmacology through his patents on prostaglandin EP3 receptor antagonists exemplify the impact of dedicated inventors in the medical field. His work continues to pave the way for future innovations in therapeutic treatments.